A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer.
about
Comparative effectiveness and safety between oxaliplatin-based and cisplatin-based therapy in advanced gastric cancer: A meta-analysis of randomized controlled trials.Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer.Paclitaxel/oxaliplatin/fluorouracil (TOF) regimen versus S-1/oxaliplatin (SOX) regimen for metastatic gastric cancer patients.Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy.S-1-based chemotherapy versus capecitabine-based chemotherapy as first-line treatment for advanced gastric carcinoma: a meta-analysis.Combined olaparib and oxaliplatin inhibits tumor proliferation and induces G2/M arrest and γ-H2AX foci formation in colorectal cancer.Decreased FANCJ caused by 5FU contributes to the increased sensitivity to oxaliplatin in gastric cancer cells.Efficacy and safety of SOX chemotherapy with or without surgery in AFP-producing advanced gastric cancer.Impact of the Surveillance Interval on the Survival of Patients Who Undergo Curative Surgery for Gastric Cancer.Results of a randomized and controlled clinical trial evaluating the efficacy and safety of combination therapy with Endostar and S-1 combined with oxaliplatin in advanced gastric cancer.Phase II trial of preoperative chemoradiation plus perioperative SOX chemotherapy in patients with locally advanced gastric cancer.Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis.
P2860
Q33432145-4479F859-8674-46BF-AA37-74CDF41E287CQ33609291-991D032D-7288-47B1-BEEA-1C52C744B99BQ33728364-86F51252-4F33-4F42-9FE4-DA137D46E770Q35060024-54001DC5-C227-482F-B814-6AD76EB53F38Q35070531-C2FE310C-C12B-4CD2-B82B-E8395C2B5286Q36211573-4D825198-4C1A-4AE5-8FAB-CEDACD268AA3Q39280872-A395F879-D4FD-4F7F-8676-9AF7AD40A417Q40141364-95276A79-9D11-4D4F-A31C-80D9B3FB3AFFQ40480332-49E281E9-F96A-447E-BBFE-40C9C5B55433Q43067439-F560A0B8-BC76-4DC4-9EFF-0021BCC84294Q48197616-4898CA5F-3BBD-42E8-9A10-65D1B4E03F5CQ53546129-404DFE06-ABCA-4BD3-B5F4-327CF587A1C4
P2860
A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A phase II study of S-1 and ox ...... with advanced gastric cancer.
@ast
A phase II study of S-1 and ox ...... with advanced gastric cancer.
@en
type
label
A phase II study of S-1 and ox ...... with advanced gastric cancer.
@ast
A phase II study of S-1 and ox ...... with advanced gastric cancer.
@en
prefLabel
A phase II study of S-1 and ox ...... with advanced gastric cancer.
@ast
A phase II study of S-1 and ox ...... with advanced gastric cancer.
@en
P2093
P2860
P1476
A phase II study of S-1 and ox ...... with advanced gastric cancer.
@en
P2093
Gyeong-won Lee
Hoon gu Kim
Hyuk-Chan Kwon
Jung Hun Kang
Myoung Hee Kang
Sang-Ho Jeong
Su hee Cho
Sung Yong Oh
Young-Joon Lee
P2860
P2888
P304
P356
10.1007/S10637-010-9507-2
P577
2010-08-13T00:00:00Z
P6179
1039747812